行业
显示 51-60 个结果（共 134 个结果）
-
Non-small-cell Lung Carcinoma (NSCLC) 中国市场
美元 10在 3% 复合年增长率, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 千单位 2027, 据数据和分析公司 StrategyHelix 称.
-
Nasopharyngeal Cancer Market in China
美元 5根据StrategyHelix的统计, the nasopharyngeal cancer market in China, 就体积而言, 预计复合年增长率为 1.2% 未来五年.
-
Head and Neck Cancer Market in China
美元 5The head and neck cancer market in China, 就体积而言, 预计复合年增长率为 1.7% 从 2021 通过 2027, 据数据和分析公司 StrategyHelix 称.
-
Global Immuno-Oncology Therapy Market
美元 10The global immuno-oncology therapy market is expected to increase at a CAGR of 22.6% 直到 2027, 据数据和分析公司 StrategyHelix 称.
-
Oncology Drug Market in China
美元 10The oncology drug market in China is poised to grow at a CAGR of around 13.3% 在分析期间 2021 到 2027, 据数据和分析公司 StrategyHelix 称.
-
Global Oncology Drug Market
美元 15根据StrategyHelix的统计, the global oncology drug market is poised to grow at a CAGR of around 12.6% 在分析期间 2021 到 2027.
-
Biomedical Materials Market in China
美元 15A statistic by StrategyHelix indicates that the biomedical materials market in China is expected to increase at a CAGR of 11.5% 直到 2027.
-
Home Use Medical Device Market in China
美元 5The home use medical device market in China is set to increase by US$ 12,122 百万来自 2021 到 2027, 代表复合年增长率 (复合年增长率) 的 10% 在预测期内.
-
Blood Glucose Market in China
美元 10The blood glucose market in China is poised to grow by US$ 18,136 期间百万 2021-2027, 复合年增长率为 22.8% 在预测期内, 据数据和分析公司 StrategyHelix 称.
-
Nutritional Supplement Market in China
美元 5The nutritional supplement market in China was around 233 m units in 2020, 到达 272 m units in 2021 (增加了 16.5% 去年同期), 根据StrategyHelix’ 分析.
